BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 30893577)

  • 1. Mineralocorticoid receptor antagonist pre-treatment and early post-treatment to minimize reperfusion injury after ST-elevation myocardial infarction: The MINIMIZE STEMI trial.
    Bulluck H; Fröhlich GM; Nicholas JM; Mohdnazri S; Gamma R; Davies J; Sirker A; Mathur A; Blackman D; Garg P; Moon JC; Greenwood JP; Hausenloy DJ
    Am Heart J; 2019 May; 211():60-67. PubMed ID: 30893577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mineralocorticoid receptor antagonist pretreatment to MINIMISE reperfusion injury after ST-elevation myocardial infarction (the MINIMISE STEMI Trial): rationale and study design.
    Bulluck H; Fröhlich GM; Mohdnazri S; Gamma RA; Davies JR; Clesham GJ; Sayer JW; Aggarwal RK; Tang KH; Kelly PA; Jagathesan R; Kabir A; Robinson NM; Sirker A; Mathur A; Blackman DJ; Ariti C; Krishnamurthy A; White SK; Meier P; Moon JC; Greenwood JP; Hausenloy DJ
    Clin Cardiol; 2015 May; 38(5):259-66. PubMed ID: 25990305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet inhibition to target reperfusion injury trial: Rationale and study design.
    Bulluck H; Chan MHH; Bryant JA; Chai P; Chawla A; Chua TS; Chung YC; Fei G; Ho HH; Ho AFW; Hoe AJ; Imran SS; Lee CH; Lim SH; Liew BW; Yun PLZ; Hock MOE; Paradies V; Roe MT; Teo L; Wong AS; Wong E; Wong PE; Watson T; Chan MY; Tan JW; Hausenloy DJ
    Clin Cardiol; 2019 Jan; 42(1):5-12. PubMed ID: 30421441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and Safety of a Pharmaco-Invasive Strategy With Half-Dose Alteplase Versus Primary Angioplasty in ST-Segment-Elevation Myocardial Infarction: EARLY-MYO Trial (Early Routine Catheterization After Alteplase Fibrinolysis Versus Primary PCI in Acute ST-Segment-Elevation Myocardial Infarction).
    Pu J; Ding S; Ge H; Han Y; Guo J; Lin R; Su X; Zhang H; Chen L; He B;
    Circulation; 2017 Oct; 136(16):1462-1473. PubMed ID: 28844990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of mineralocorticoid receptor antagonist eplerenone on cardiac sympathetic nerve activity and left ventricular remodeling after reperfusion therapy in patients with first ST-segment elevation myocardial infarction.
    Toda K; Kasama S; Toyama T; Kasahara M; Kurabayashi M
    J Nucl Cardiol; 2022 Oct; 29(5):2325-2335. PubMed ID: 34272676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognosis-based definition of left ventricular remodeling after ST-elevation myocardial infarction.
    Reindl M; Reinstadler SJ; Tiller C; Feistritzer HJ; Kofler M; Brix A; Mayr A; Klug G; Metzler B
    Eur Radiol; 2019 May; 29(5):2330-2339. PubMed ID: 30547201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early Aldosterone Blockade in Acute Myocardial Infarction: The ALBATROSS Randomized Clinical Trial.
    Beygui F; Cayla G; Roule V; Roubille F; Delarche N; Silvain J; Van Belle E; Belle L; Galinier M; Motreff P; Cornillet L; Collet JP; Furber A; Goldstein P; Ecollan P; Legallois D; Lebon A; Rousseau H; Machecourt J; Zannad F; Vicaut E; Montalescot G;
    J Am Coll Cardiol; 2016 Apr; 67(16):1917-27. PubMed ID: 27102506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unloading the Left Ventricle Before Reperfusion in Patients With Anterior ST-Segment-Elevation Myocardial Infarction.
    Kapur NK; Alkhouli MA; DeMartini TJ; Faraz H; George ZH; Goodwin MJ; Hernandez-Montfort JA; Iyer VS; Josephy N; Kalra S; Kaki A; Karas RH; Kimmelstiel CD; Koenig GC; Lau E; Lotun K; Madder RD; Mannino SF; Meraj PM; Moreland JA; Moses JW; Kim RL; Schreiber TL; Udelson JE; Witzke C; Wohns DHW; O'Neill WW
    Circulation; 2019 Jan; 139(3):337-346. PubMed ID: 30586728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized Trial of Interleukin-6 Receptor Inhibition in Patients With Acute ST-Segment Elevation Myocardial Infarction.
    Broch K; Anstensrud AK; Woxholt S; Sharma K; Tøllefsen IM; Bendz B; Aakhus S; Ueland T; Amundsen BH; Damås JK; Berg ES; Bjørkelund E; Bendz C; Hopp E; Kleveland O; Stensæth KH; Opdahl A; Kløw NE; Seljeflot I; Andersen GØ; Wiseth R; Aukrust P; Gullestad L
    J Am Coll Cardiol; 2021 Apr; 77(15):1845-1855. PubMed ID: 33858620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Remote ischemic post-conditioning of the lower limb during primary percutaneous coronary intervention safely reduces enzymatic infarct size in anterior myocardial infarction: a randomized controlled trial.
    Crimi G; Pica S; Raineri C; Bramucci E; De Ferrari GM; Klersy C; Ferlini M; Marinoni B; Repetto A; Romeo M; Rosti V; Massa M; Raisaro A; Leonardi S; Rubartelli P; Oltrona Visconti L; Ferrario M
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1055-63. PubMed ID: 24156966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracoronary compared with intravenous bolus tirofiban on the microvascular obstruction in patients with STEMI undergoing PCI: a cardiac MR study.
    Ma Q; Ma Y; Wang X; Li S; Yu T; Duan W; Wu J; Wen Z; Jiao Y; Sun Z; Hou Y
    Int J Cardiovasc Imaging; 2020 Jun; 36(6):1121-1132. PubMed ID: 32078096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of spironolactone on cardiac sympathetic nerve activity and left ventricular remodelling after reperfusion therapy in patients with first ST-segment elevation myocardial infarction.
    Kasama S; Toyama T; Sumino H; Kumakura H; Takayama Y; Minami K; Ichikawa S; Matsumoto N; Sato Y; Kurabayashi M
    Heart; 2011 May; 97(10):817-22. PubMed ID: 21378011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. UpStreAm doxycycline in ST-eLeVation myocArdial infarction: targetinG infarct hEaling and ModulatIon (SALVAGE-MI trial).
    Noaman S; Neil C; O'Brien J; Frenneaux M; Hare J; Wang B; Yee Tai T; Theuerle J; Shaw J; Stub D; Bloom J; Walton A; Duffy SJ; Peter KH; Cox N; Kaye DM; Taylor A; Chan W
    Eur Heart J Acute Cardiovasc Care; 2023 Apr; 12(3):143-152. PubMed ID: 36567466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of the Use of Mineralocorticoid Receptor Antagonists in Patients With Left Ventricular Dysfunction Post-ST-Segment-Elevation Myocardial Infarction.
    Wong EC; Fordyce CB; Wong G; Lee T; Perry-Arnesen M; Mackay M; Singer J; Cairns JA; Turgeon RD
    J Am Heart Assoc; 2021 Jul; 10(14):e019167. PubMed ID: 34227405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ST2 and left ventricular remodeling after ST-segment elevation myocardial infarction: A cardiac magnetic resonance study.
    Miñana G; Núñez J; Bayés-Genís A; Revuelta-López E; Ríos-Navarro C; Núñez E; Chorro FJ; López-Lereu MP; Monmeneu JV; Lupón J; Bodí V
    Int J Cardiol; 2018 Nov; 270():336-342. PubMed ID: 29954670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NHLBI-Sponsored Randomized Trial of Postconditioning During Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction.
    Traverse JH; Swingen CM; Henry TD; Fox J; Wang YL; Chavez IJ; Lips DL; Lesser JR; Pedersen WR; Burke NM; Pai A; Lindberg JL; Garberich RF
    Circ Res; 2019 Mar; 124(5):769-778. PubMed ID: 30602360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complete Revascularization Versus Culprit Lesion Only in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease: A DANAMI-3-PRIMULTI Cardiac Magnetic Resonance Substudy.
    Kyhl K; Ahtarovski KA; Nepper-Christensen L; Ekström K; Ghotbi AA; Schoos M; Göransson C; Bertelsen L; Helqvist S; Holmvang L; Jørgensen E; Pedersen F; Saunamäki K; Clemmensen P; De Backer O; Høfsten DE; Køber L; Kelbæk H; Vejlstrup N; Lønborg J; Engstrøm T
    JACC Cardiovasc Interv; 2019 Apr; 12(8):721-730. PubMed ID: 31000010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Individual participant data analysis of two trials on aldosterone blockade in myocardial infarction.
    Beygui F; Van Belle E; Ecollan P; Machecourt J; Hamm CW; Lopez De Sa E; Flather M; Verheugt FWA; Vicaut E; Zannad F; Pitt B; Montalescot G
    Heart; 2018 Nov; 104(22):1843-1849. PubMed ID: 29695512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Liraglutide on Reperfusion Injury in Patients With ST-Segment-Elevation Myocardial Infarction.
    Chen WR; Chen YD; Tian F; Yang N; Cheng LQ; Hu SY; Wang J; Yang JJ; Wang SF; Gu XF
    Circ Cardiovasc Imaging; 2016 Dec; 9(12):. PubMed ID: 27940956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Redefining Adverse and Reverse Left Ventricular Remodeling by Cardiovascular Magnetic Resonance Following ST-Segment-Elevation Myocardial Infarction and Their Implications on Long-Term Prognosis.
    Bulluck H; Carberry J; Carrick D; McEntegart M; Petrie MC; Eteiba H; Hood S; Watkins S; Lindsay M; Mahrous A; Ford I; Oldroyd KG; Berry C
    Circ Cardiovasc Imaging; 2020 Jul; 13(7):e009937. PubMed ID: 32689822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.